These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2366567)

  • 1. Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts.
    Vinten-Johansen J; Chiantella V; Johnston WE; Jolly BT; Kendricks WD; Hester TO; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):65-76. PubMed ID: 2366567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine hearts.
    Vinten-Johansen J; Nakanishi K; Zhao ZQ; McGee DS; Tan P
    Circulation; 1993 Nov; 88(5 Pt 2):II350-8. PubMed ID: 8222178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium.
    Partington MT; Acar C; Buckberg GD; Julia PL
    J Thorac Cardiovasc Surg; 1989 Apr; 97(4):613-22. PubMed ID: 2927165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of left ventricular venting and distention during heterogenous distribution of cardioplegic solution.
    Lazar HL; Wilcox K; Hankins T; Plehn J; Roberts AJ
    J Thorac Cardiovasc Surg; 1988 Mar; 95(3):501-7. PubMed ID: 3343857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protection with blood cardioplegia in ischemically injured hearts: reduction of reoxygenation injury with allopurinol.
    Vinten-Johansen J; Chiantella V; Faust KB; Johnston WE; McCain BL; Hartman M; Mills SA; Hester TO; Cordell AR
    Ann Thorac Surg; 1988 Mar; 45(3):319-26. PubMed ID: 3348704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction.
    Nakanishi K; Zhao ZQ; Vinten-Johansen J; Hudspeth DA; McGee DS; Hammon JW
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1146-54. PubMed ID: 7776679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest.
    Krukenkamp I; Silverman N; Sorlie D; Pridjian A; Feinberg H; Levitsky S
    J Thorac Cardiovasc Surg; 1986 Jul; 92(1):56-62. PubMed ID: 3724227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.
    Julia PL; Buckberg GD; Acar C; Partington MT; Sherman MP
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):303-13. PubMed ID: 1992241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):294-302. PubMed ID: 1992240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of postischemic contractile function is depressed by antegrade warm continuous blood cardioplegia.
    Misare BD; Krukenkamp IB; Lazer ZP; Levitsky S
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):37-44. PubMed ID: 8419707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection in the failing heart: I. Effect of cardioplegia and the beating state under simulated left ventricular restoration.
    Kostelec M; Covell J; Buckberg GD; Sadeghi A; Hoffman JI; Kassab GS
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):875-83. PubMed ID: 17000300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is protection of ischemic neonatal myocardium by cardioplegia species dependent?
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1990 Feb; 99(2):280-7. PubMed ID: 2299865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.
    Rosenkranz ER; Okamoto F; Buckberg GD; Robertson JM; Vinten-Johansen J; Bugyi HI
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):428-35. PubMed ID: 3951246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of the myocardium during global ischemia. Is crystalloid cardioplegia effective in the immature myocardium?
    Avkiran M; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):220-8. PubMed ID: 2915557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
    Greenfield DT; Greenfield LJ; Hess ML
    J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.